Robey RW - Search Results

1

MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor.

Chakraborty AR, Robey RW, Luchenko VL, Zhan Z, Piekarz RL, Gillet JP, Kossenkov AV, Wilkerson J, Showe LC, Gottesman MM, Collie NL, Bates SE. Chakraborty AR, et al. Among authors: robey rw. Blood. 2013 May 16;121(20):4115-25. doi: 10.1182/blood-2012-08-449140. Epub 2013 Mar 26. Blood. 2013. PMID: 23532732 Free PMC article.

2

Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay.

Kang YK, Zhan Z, Regis J, Alvarez M, Robey R, Meadows B, Dickstein B, Lee JS, Otsuki T, Stetler-Stevenson M, et al. Kang YK, et al. Blood. 1995 Aug 15;86(4):1515-24. Blood. 1995. PMID: 7632959 Free article. Clinical Trial.

3

Chemoresistance in the clinic: overview 1994.

Bates SE, Regis JI, Robey RW, Zhan Z, Scala S, Meadows BJ. Bates SE, et al. Among authors: robey rw. Bull Cancer. 1994 Dec;81 Suppl 2:55s-61s. Bull Cancer. 1994. PMID: 7727860 Review.

4

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE. Wosikowski K, et al. Among authors: robey rw. Cell Growth Differ. 1995 Nov;6(11):1395-403. Cell Growth Differ. 1995. PMID: 8562478

5

Clinical reversal of multidrug resistance.

Bates SE, Wilson WH, Fojo AT, Alvarez M, Zhan Z, Regis J, Robey R, Hose C, Monks A, Kang YK, Chabner B. Bates SE, et al. Stem Cells. 1996 Jan;14(1):56-63. doi: 10.1002/stem.140056. Stem Cells. 1996. PMID: 8820952 Review.

6

Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.

Lee JS, Scala S, Matsumoto Y, Dickstein B, Robey R, Zhan Z, Altenberg G, Bates SE. Lee JS, et al. J Cell Biochem. 1997 Jun 15;65(4):513-26. J Cell Biochem. 1997. PMID: 9178101

7

Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833.

Robey R, Bakke S, Stein W, Meadows B, Litman T, Patil S, Smith T, Fojo T, Bates S. Robey R, et al. Blood. 1999 Jan 1;93(1):306-14. Blood. 1999. PMID: 9864175 Free article. Clinical Trial.

8

Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE. Miyake K, et al. Cancer Res. 1999 Jan 1;59(1):8-13. Cancer Res. 1999. PMID: 9892175

9

Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells.

Blagosklonny MV, Bishop PC, Robey R, Fojo T, Bates SE. Blagosklonny MV, et al. Cancer Res. 2000 Jul 1;60(13):3425-8. Cancer Res. 2000. PMID: 10910051

10

Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells.

Kitazono M, Robey R, Zhan Z, Sarlis NJ, Skarulis MC, Aikou T, Bates S, Fojo T. Kitazono M, et al. J Clin Endocrinol Metab. 2001 Jul;86(7):3430-5. doi: 10.1210/jcem.86.7.7621. J Clin Endocrinol Metab. 2001. PMID: 11443220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters